Cernostics CEO on the opportunities ahead with Castle’s acquisition
Cernostics CEO Michael Hoerres said his biotech company’s presence will not just remain but grow in Pittsburgh with the Read More
Research Validates Tissue Pathology Test Predicting Progression in Barrett’s Esophagus
Objective risk assessment guides surveillance and treatment
Patients with Barrett’s es Read More
Improved Testing for Barrett's Esophagus
This is a companion article to the CLP feature, “Read More
NewCo on the Go: Cernostics aims to help GIs manage Barrett’s patients
Gastroenterologists are usually quick to admit they do not have a good way to manage patients with Barrett’s esophagus. Read More
Load More Posts